U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07429890) titled 'REVIVE Prospective Registry Cohort Study' on Jan. 24.
Brief Summary: The main purpose of this registry is to collect observational, long-term safety and effectiveness data in participants who have received iltamiocel as part of the blinded portion of the REVIVE clinical study.
Study Start Date: Feb. 15
Study Type: OBSERVATIONAL
Condition:
Oropharyngeal Dysphagia
Intervention:
OTHER: Other: No Intervention (subjects were previously treated with Iltamiocel). This is a observational study and all participants will be observed with no intervention.
Participants are followed observationally to collect long-term safety and effectiv...